These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4916544)

  • 1. What is the antibody specificity of LATS?
    Fagraeus A; Jonsson J; el-Kabir DJ
    J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
    [No Abstract]   [Full Text] [Related]  

  • 2. Can LATS be detected by immunofluorescence?
    Beall GN; Solomon DH; Doniach D; Roitt IM
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1114-6. PubMed ID: 4895860
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
    Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
    Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence to suggest that LATS protector stimulates the human thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure to detect long-acting thyroid stimulator with the immunofluorescence technique.
    Fedder G; Feltkamp TE
    Clin Exp Immunol; 1970 Jan; 6(1):167-8. PubMed ID: 4906525
    [No Abstract]   [Full Text] [Related]  

  • 8. LATS and thyroid autoantibodies.
    Beall GN; Solomon DH
    Clin Exp Immunol; 1968 Sep; 3(7):615-9. PubMed ID: 4883066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J; Pousset G; Durand H
    Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
    Adams DD; Kennedy TH; Stewart RD
    Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
    Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
    J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between the long-acting thyroid stimulator and circulating thyroid antibodies in Graves' disease.
    Pinchera A; Liberti P; De Santis R; Grasso L; Martino E; Baschieri L
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1758-60. PubMed ID: 6072765
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-acting thyroid stimulator and thyroid function in relatives of patients with Graves' disease.
    Bonnyns M; Vanhaerlst L; Golstein J; Cauchie C; Ermans AM; Bastenie PA
    Clin Endocrinol (Oxf); 1973 Jul; 2(3):277-87. PubMed ID: 4128244
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological mechanisms in thyrotoxicosis].
    Bradistilov S
    Vutr Boles; 1979; 18(2):9-16. PubMed ID: 380170
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED; Dentinger M
    Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of anti-thyroid antibody].
    Shishiba Y
    Nihon Rinsho; 1979 Jun; Suppl():1511-4. PubMed ID: 226738
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in LATS and other thyoid autoantibody levels with therapy.
    Kilpatrick JA
    N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.